Warren Buffett has upped his stake in DaVita (DVA), one of the largest kidney care companies in the United States. According to Securities and Exchange Commission, Warren Buffett and Berkshire Hathaway (BRK.A, BRK.B) increased its stake in DVA stock after DaVita earnings were released last week.
The documents indicated that Warren Buffett and Berkshire acquired an additional 3.7 million shares of DVA stock, boosting its stake in the firm to about 16.5%.
Warren Buffett and Berkshire now hold 35.1 million shares of DaVita, which operates almost 2,000 dialysis clinics. But Buffett and his firm have an agreement not to increase their stake in DVA stock above 25% without the company’s consent.
In August, DaVita announced a 2-for-1 split of DVA stock, effective in late September. That increased its number of outstanding shares above 212 million.
Warren Buffett and Berkshire Hathaway have been purchasing DaVita stock for more than two years.
Shares of DVA stock gained almost 2% in Monday morning trading. DVA is up only 3% year-to-date, though, and 1% over the last 12 months thanks to the stock split.